MedTrace Logo

[14 C] Study on Mass Balance of TY-9591 in Healthy Chinese Subjects

NCT05871905 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2024-12-30

No results posted yet for this study

Summary

\[14 C\] Mass balance clinical trial of TY-9591 in healthy Chinese subjects

Conditions

  • Healthy Volunteers

Interventions

DRUG

TY-9591

C14 TY-9591

Sponsors & Collaborators

  • TYK Medicines, Inc

    lead INDUSTRY

Principal Investigators

  • Mu Liyan · Suzhou First People's Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-19
Primary Completion
2023-11-06
Completion
2024-06-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05871905 on ClinicalTrials.gov